1. Home
  2. BWAY

BWAY

BrainsWay Ltd.

Logo BrainsWay Ltd.

Health Care

Medical/Dental Instruments

Nasdaq

as 04-16-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Founded: 2003 Country:
Israel
Israel
Employees: N/A City: N/A
Market Cap: 93.5M IPO Year: 2019
Target Price: $9.50 AVG Volume (30 days): 113.5K
Analyst Decision: Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.26 EPS Growth: N/A
52 Week Low/High: $1.38 - $7.62 Next Earning Date: 05-15-2024
Revenue: $31,785,000 Revenue Growth: 16.96%
Revenue Growth (this year): 349.93% Revenue Growth (next year): 18.50%

Share on Social Networks: